24/10/2025

Senores Pharmaceuticals Ltd

BSE: 544319 NSE: SENORES

About the Company

Incorporated in 2015, Senores Pharmaceuticals Ltd manufactures and develops affordable and high-quality complex generics certified by global food and drugs authorities
Pros
  • Company has reduced debt.
  • Company is almost debt free.
  • Company is expected to give good quarter
VS
Cons
  • Stock is trading at 5.30 times its book value
  • Though the company is reporting repeated profits
  • it is not paying out dividend
  • Company has a low return on equity of 0.99% over last 3 years.
  • Earnings include an other income of Rs.36.2 Cr.
  • Company has high debtors of 243 days.
  • Working capital days have increased from -372 days to 105 days
Stock PE: 309
ROCE: 2.15
Market Cap: 3774 Cr.
Book Value: 155
ROE: 0.84
Face Value: 10
Credit Report: View PDF

SENORES - Price Chart


Volume Chart

Last 30 Days Bulk Deals

SL# Symbol Name Date Client Buy/Sell Quantity Price Remark
1 SENORES Senores Pharmaceuticals L 24/12/2025 ASTORNE CAPITAL VCC ARVEN SELL 500,000 792 -
SL# Symbol Name Date Client Buy/Sell Quantity Price Remark
Technical Indicators
Today's OPEN >= LOW and HIGH=CLOSE No
Is a 7 Days Breakout ? Yes
3 Days Consecutive Volume Spike: Yes
2 Days Consecutive Price Hike: Yes
Above 20 MA ? Above
Above 50 MA ? Above
Above 100 MA ? Above
Above 200 MA ? Above

Important Disclaimer

One Page Analysis is calculated on the basis of Technical factors. No News or Result-oriented factors were considered.

This is a free tool only to help traders on a technical basis.

* Consult your financial advisor before investing in a strong market as it is subject to high risk.